Long-term 5-year mortality conditional on successful discharge after implantation with a fully magnetically levitated HeartMate 3 (HM3) left ventricular assist device (LVAD) is largely influenced by clinical events experienced during the index surgical hospitalization, in concert with preimplant factors, according to a new analysis of 5-year follow-up data from the MOMENTUM 3 trial.